Immunology
Feature
Highly anticipated HIV vaccine fails in large trial
The vaccine had been in development since 2019 and was given to 3,900 study participants through October 2022.
From the Journals
Scientists use mRNA technology for universal flu vaccine
Two years ago marked a significant moment for messenger RNA (mRNA) technology.
Feature
COVID booster shot poll: People ‘don’t think they need one’
A new poll shows why so few people are willing to get the latest COVID booster.
Feature
As COVID treatments dwindle, are new ones waiting in the wings?
Bebtelovimab couldn’t neutralize the Omicron subvariants BQ.1 and BQ.1.1.
Feature
Have you heard of VEXAS syndrome?
The prevalence of this syndrome is unknown, but it is not so rare.
Feature
Have long COVID? Newest booster vaccines may help you
‘A bivalent booster might actually [help with] your long COVID,’ epidemiologist said.
News
FDA pulls U.S. authorization for Eli Lilly’s COVID drug bebtelovimab
The drug is not expected to neutralize the dominant BQ.1 and BQ.1.1 subvariants of Omicron.
Feature
Buzzy Lancet long COVID paper under investigation for ‘data errors’
A reader found inconsistencies between the data in the article and a later paper describing the same cohort of patients after a year of follow-up...
Feature
Covid vax prevents death in children regardless of variant
But the vaccine’s effectiveness decreased over time.
Feature
More vaccinated people dying of COVID as fewer get booster shots
But the case for the effectiveness of vaccines and boosters versus skipping the shots remains strong.
From the Journals
Add tezepelumab to SCIT to improve cat allergy symptoms?
“Tezepelumab is currently an expensive biologic, so it remains to be seen whether patients and payors will be willing to pay for this add-on...